MVA E2 vaccine (Universidad Nacional Autonoma De Mexico)

N/A

Report date: 2024/12/11 10:05:01

Base Information

Drug NameMVA E2 vaccine (Universidad Nacional Autonoma De Mexico)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory papillomatosisCervical Intraepithelial Neoplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInstituto Nacional Salvador ZubiranUniversidad Nacional Autonoma Mexico
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversidad Nacional Autonoma MexicoInstituto Nacional Salvador Zubiran
Active IndicationsN/A
Inactive IndicationsRespiratory papillomatosisCervical Intraepithelial Neoplasia

Other Information

ATC CodeN/A
Related LinksN/A